EUVIMEDEUVIMED entdecken
Crossref

Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer

Motonobu Uchiyama, Hiroaki Shima, Goro Kutomi, Daisuke Kyuno, Asaka Wada, Yoko Kuga, Yasuaki Tamura, Yoshihiko Hirohashi, Toshihiko Torigoe, Ichiro Takemasa

Anticancer Research · 2024

DOI: 10.21873/anticanres.17233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Motonobu Uchiyama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHistocompatibility Antigens Class IHumansFemaleMiddle AgedPrognosisAgedAdultBiomarkers, TumorDisease-Free SurvivalKaplan-Meier EstimateAged, 80 and overLymphocytes, Tumor-InfiltratingCD8-Positive T-LymphocytesImmunohistochemistry

Stichwörter der Autor:innen

HLA class Ibreast cancerprognosis

Substanzen

Histocompatibility Antigens Class IBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan.
  • Department of Surgery, Monbetsu General Hospital, Monbetsu, Japan.
  • Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan; simahiro@sapmed.ac.jp.
  • Department of Breast Oncology, Juntendo University School of Medicine, Bunkyo, Japan.
  • Department of Pathology, Sapporo Medical University, Sapporo, Japan.
  • Department of Breast Surgical Oncology, St. Luke's International Hospital, Chuo, Japan.

Zitieren

APA

Uchiyama, M., Shima, H., Kutomi, G., Kyuno, D., Wada, A., Kuga, Y., Tamura, Y., Hirohashi, Y., Torigoe, T., & Takemasa, I. (2024). Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17233

Vancouver

Uchiyama M, Shima H, Kutomi G, Kyuno D, Wada A, Kuga Y, et al. Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17233

BibTeX
@article{Uchiyama2024,
  author = {Uchiyama, Motonobu and Shima, Hiroaki and Kutomi, Goro and Kyuno, Daisuke and Wada, Asaka and Kuga, Yoko and Tamura, Yasuaki and Hirohashi, Yoshihiko and Torigoe, Toshihiko and Takemasa, Ichiro},
  title = {Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17233}
}
Kostenlos starten →